GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioiasis AD (XBUL:BIOA) » Definitions » Capex-to-Revenue

Bioiasis AD (XBUL:BIOA) Capex-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Bioiasis AD Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Bioiasis AD's Capital Expenditure for the three months ended in Mar. 2024 was лв0.00 Mil. Its Revenue for the three months ended in Mar. 2024 was лв0.20 Mil.

Hence, Bioiasis AD's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.00.


Bioiasis AD Capex-to-Revenue Historical Data

The historical data trend for Bioiasis AD's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioiasis AD Capex-to-Revenue Chart

Bioiasis AD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bioiasis AD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bioiasis AD's Capex-to-Revenue

For the Medical Devices subindustry, Bioiasis AD's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioiasis AD's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioiasis AD's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bioiasis AD's Capex-to-Revenue falls into.



Bioiasis AD Capex-to-Revenue Calculation

Bioiasis AD's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.012
=0.00

Bioiasis AD's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioiasis AD  (XBUL:BIOA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Bioiasis AD Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bioiasis AD's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioiasis AD (XBUL:BIOA) Business Description

Traded in Other Exchanges
N/A
Address
60, Deyan Belishki Str., Ground Floor, Sofia, BGR, 1404
Bioiasis AD provides specialized medical devices, equipment, and consultation services to state and private hospitals and trading companies. The company also deals in Interventional Cardiology and General Surgery consumables.

Bioiasis AD (XBUL:BIOA) Headlines

No Headlines